Egis World
Egis' products are sold to 100 countries.

Egis announces further investments at its Körmend site
Over the next few years, Egis Pharmaceuticals PLC will invest EUR 21.1 million to increase its capacity at its Körmend site. To finance these developments, Egis will use its own capital and a government subsidy of EUR 3.4 million – announced Csaba Poroszlai, CEO of Egis. In total, the company will devote more than EUR 50 million to the development of the Körmend site of Egis since 2019. More

Csaba Poroszlai is CEO of Egis Pharmaceuticals PLC

Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer. More

Dr István Hodász, former CEO of Egis becomes honorary citizen of Kőbánya

The recognition can be bestowed on a person who - through their activities, work, and attitude - has contributed to the development and growth of the district and thus raised the reputation of Kőbánya. More

Night of Museums - first time at Egis

The Egis Science and Technology Centre welcomes visitors on the longest night of the year

More

A unique chemistry competition sponsored by Egis

Although the Researchers' Night will not take place until autumn, one of the side events of the large-scale event is already open for registration: the thought-provoking chemistry competition is sponsored by Egis.

More

Csaba Poroszlai elected vice president of MAGYOSZ

Mr. Csaba Poroszlai, CEO of Egis and dr Tamás Rónay CEO of Sanofi-Aventis and Chinoin were elected vice presidents of the Hungarian Pharmaceutical Manufacturers’ Association (MAGYOSZ) at the Association’s annual general meeting. The executive director of Meditop Kft., dr Dávid Greskovits, will hold the position of president for another three years. Mr. Csaba Poroszlai has also become the member of the presidential board.

More

Egis hosted jobseekers in five job fairs

There were five opportunities to meet us this spring.

More
Other channels
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
Health
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products
Innovation
In the 2022/2023 business year, we spent EUR 48 million on research and development
Corporate Social Responsibility
Healthcare and sharing knowledge are in the heart of our CSR activities
Events
Our highlighted past and future events you shouldn't miss

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox